Ministry of Health Confirms Five Cases of Monkeypox in MexicoBy Rodrigo Andrade | Fri, 06/17/2022 - 16:52
Hugo López-Gatell, Deputy Minister of Health, confirmed the presence of five monkeypox cases in Mexico, four of them in Mexico City and one in Jalisco. Despite the growing number of cases, López-Gatell discarded the possibility of a pandemic similar to COVID-19. “We have five cases in Mexico, four in Mexico City, one confirmed in Jalisco, although the patient was from the US. We are going to find cases sporadically. Of these five, one was infected by another from the same group, but there is no information that it is going to become a pandemic like COVID-19,” said López-Gatell.
The four cases in Mexico City were likely infected by a member of that same group, he added. While there are two vaccines that prevent related diseases, such as smallpox, they do not cure monkeypox. “There are two vaccines that provide mediocre protection against monkeypox and there is a drug that does not provide a definitive solution,” said López-Gatell.
The first cases linked to this latest monkeypox outbreak were confirmed on May 13, 2022, with the UK being the first non-endemic country to report cases. Monkeypox symptoms include a rash, fever, headaches, muscle aches, low energy and swollen lymph nodes, as previously reported by MBN. Symptoms usually disappear within 14-21 days. To prevent it, the World Health Organization (WHO) recommends avoiding contact with those with symptoms, hand washing and the use of a mask if close contact cannot be avoided.”
Experts agree that monkeypox is transmitted from person to person only by direct contact, meaning there is no transmission by air, food or water contamination. The efficiency of contagion is low. “The current epidemiology of monkeypox cases is unusual, because most cases are unlinked and will mean that vigilance is required across the world, but unlike SARS-CoV-2 this virus is better understood and methods to prevent its spread can be actioned swiftly,” said David Tscharke, Head of the Department of Immunology and Infectious Diseases, John Curtin School of Medical Research.